These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 38576716)

  • 1. Methodological biases in observational hospital studies of COVID-19 treatment effectiveness: pitfalls and potential.
    Martinuka O; Hazard D; Marateb HR; Mansourian M; Mañanas MÁ; Romero S; Rubio-Rivas M; Wolkewitz M
    Front Med (Lausanne); 2024; 11():1362192. PubMed ID: 38576716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Target trial emulation with multi-state model analysis to assess treatment effectiveness using clinical COVID-19 data.
    Martinuka O; Hazard D; Marateb HR; Maringe C; Mansourian M; Rubio-Rivas M; Wolkewitz M
    BMC Med Res Methodol; 2023 Sep; 23(1):197. PubMed ID: 37660025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Target Trial Emulation Using Hospital-Based Observational Data: Demonstration and Application in COVID-19.
    Martinuka O; Cube MV; Hazard D; Marateb HR; Mansourian M; Sami R; Hajian MR; Ebrahimi S; Wolkewitz M
    Life (Basel); 2023 Mar; 13(3):. PubMed ID: 36983933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methodological evaluation of bias in observational coronavirus disease 2019 studies on drug effectiveness.
    Martinuka O; von Cube M; Wolkewitz M
    Clin Microbiol Infect; 2021 Jul; 27(7):949-957. PubMed ID: 33813117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reflection on modern methods: trial emulation in the presence of immortal-time bias. Assessing the benefit of major surgery for elderly lung cancer patients using observational data.
    Maringe C; Benitez Majano S; Exarchakou A; Smith M; Rachet B; Belot A; Leyrat C
    Int J Epidemiol; 2020 Oct; 49(5):1719-1729. PubMed ID: 32386426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation of the trial emulation approach in medical research: a scoping review.
    Scola G; Chis Ster A; Bean D; Pareek N; Emsley R; Landau S
    BMC Med Res Methodol; 2023 Aug; 23(1):186. PubMed ID: 37587484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of bias in observational studies using routinely collected data of comparative effectiveness research: a meta-research study.
    Nguyen VT; Engleton M; Davison M; Ravaud P; Porcher R; Boutron I
    BMC Med; 2021 Nov; 19(1):279. PubMed ID: 34809637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emulating a Target Trial of Interventions Initiated During Pregnancy with Healthcare Databases: The Example of COVID-19 Vaccination.
    Hernández-Díaz S; Huybrechts KF; Chiu YH; Yland JJ; Bateman BT; Hernán MA
    Epidemiology; 2023 Mar; 34(2):238-246. PubMed ID: 36722806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Timing, the Treatment, the Question: Comparison of Epidemiologic Approaches to Minimize Immortal Time Bias in Real-World Data Using a Surgical Oncology Example.
    Duchesneau ED; Jackson BE; Webster-Clark M; Lund JL; Reeder-Hayes KE; Nápoles AM; Strassle PD
    Cancer Epidemiol Biomarkers Prev; 2022 Nov; 31(11):2079-2086. PubMed ID: 35984990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-Blockers in COPD: A Methodological Review of the Observational Studies.
    Suissa S; Ernst P
    COPD; 2018 Oct; 15(5):520-525. PubMed ID: 30822238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Causal analyses with target trial emulation for real-world evidence removed large self-inflicted biases: systematic bias assessment of ovarian cancer treatment effectiveness.
    Kuehne F; Arvandi M; Hess LM; Faries DE; Matteucci Gothe R; Gothe H; Beyrer J; Zeimet AG; Stojkov I; Mühlberger N; Oberaigner W; Marth C; Siebert U
    J Clin Epidemiol; 2022 Dec; 152():269-280. PubMed ID: 36252741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bariatric surgery and all-cause mortality: A methodological review of studies using a non-surgical comparator.
    Suissa K; Schneeweiss S; Glynn RJ; Wexler DJ; Suissa S; Paik JM; Patorno E
    Diabetes Obes Metab; 2024 Oct; 26(10):4273-4280. PubMed ID: 39014528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specifying a target trial prevents immortal time bias and other self-inflicted injuries in observational analyses.
    Hernán MA; Sauer BC; Hernández-Díaz S; Platt R; Shrier I
    J Clin Epidemiol; 2016 Nov; 79():70-75. PubMed ID: 27237061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival biases lead to flawed conclusions in observational treatment studies of influenza patients.
    Wolkewitz M; Schumacher M
    J Clin Epidemiol; 2017 Apr; 84():121-129. PubMed ID: 28188897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How unmeasured confounding in a competing risks setting can affect treatment effect estimates in observational studies.
    Barrowman MA; Peek N; Lambie M; Martin GP; Sperrin M
    BMC Med Res Methodol; 2019 Jul; 19(1):166. PubMed ID: 31366331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allopurinol and Cardiovascular Events: Time-Related Biases in Observational Studies.
    Suissa S; Suissa K; Hudson M
    Arthritis Care Res (Hoboken); 2022 May; 74(5):858-865. PubMed ID: 34057310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival analysis for AdVerse events with VarYing follow-up times (SAVVY)-estimation of adverse event risks.
    Stegherr R; Schmoor C; Beyersmann J; Rufibach K; Jehl V; Brückner A; Eisele L; Künzel T; Kupas K; Langer F; Leverkus F; Loos A; Norenberg C; Voss F; Friede T
    Trials; 2021 Jun; 22(1):420. PubMed ID: 34187527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statins and Mortality in COPD: A Methodological Review of Observational Studies.
    Sule NO; Suissa S
    COPD; 2023 Dec; 20(1):284-291. PubMed ID: 37555454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statins and lower mortality in rheumatic diseases: An effect of immortal time bias?
    Abrahami D; Hudson M; Suissa S
    Semin Arthritis Rheum; 2021 Feb; 51(1):211-218. PubMed ID: 33385861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.